What Researchers Did
Researchers reported the first documented case of a child with congenital insensitivity to pain with anhidrosis (CIPA) treated with HBOT for chronic osteomyelitis and pseudoarthrosis using 40 sessions at 2.4 ATA.
What They Found
The child demonstrated progressive bone healing and resolution of the chronic infection following HBOT. This was the first reported use of HBOT for this combination of conditions in a pediatric patient.
What This Means for Canadian Patients
CIPA is an extremely rare genetic condition; however, this case expands the evidence base for HBOT in complex pediatric bone infections when standard treatments have failed.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
A single pediatric case report cannot generalize to other patients, and the unique nature of CIPA limits applicability.